Genetic modifications in PCSK9 enhancing its LDLR-degrading function are linked to FH.118 In an epidemiological setting, an array of PCSK9’s single-nucleotide polymorphisms (SNPs) associated with average blood cholesterol levels that deviate from the age-adjusted normal references. The gene discussed is PCSK9; the disease is familial hyperaldosteronism.